Fundraising FoxBiolattice Ophthalmics, Inc.
Philadelphia, US · Founded 2023 · Delaware corporation · 3 known investors
Find your way into Biolattice Ophthalmics, Inc.
Sign up to see every warm intro you have to Biolattice Ophthalmics, Inc.
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Biolattice Ophthalmics, Inc. team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
BioLattice develops engineered cornea tissue as an alternative to donor cornea for patients with corneal blindness and those waiting for transplants. The company focuses on tissue engineering to address the shortage of donor cornea supply in the global ophthalmology market.
Founders & leadership
Board
GJ
Investors · 3
Reported raises · per SEC filings
Form D private placements$575K disclosed across 1 round · 2026
▶$575KraisedMar 2026 · 2 investors · BiotechnologyRule 506(b)
▶$575KraisedMar 2026 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Gregory JacksonDirector
- Amelia ZellanderExecutive Officer, Director
- Linda AlunkalExecutive Officer, Director
- Offering amount
- $2.5M
- Amount sold
- $575K
- First sale
- Mar 2026
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 1
Companies working in the same space as Biolattice Ophthalmics, Inc..
Frequently asked questions
- What does Biolattice Ophthalmics, Inc. do?
- BioLattice develops engineered cornea tissue as an alternative to donor cornea for patients with corneal blindness and those waiting for transplants. The company focuses on tissue engineering to address the shortage of donor cornea supply in the global ophthalmology market.
- Who are Biolattice Ophthalmics, Inc.'s investors?
- Biolattice Ophthalmics, Inc.'s investors include Life Sciences Greenhouse Investments, Robin Hood Ventures, SOSV.
- How much funding has Biolattice Ophthalmics, Inc. raised?
- Biolattice Ophthalmics, Inc. has disclosed $575K raised across 1 round.
- Where is Biolattice Ophthalmics, Inc. headquartered?
- Biolattice Ophthalmics, Inc. is headquartered in Philadelphia, US.